Your current location:  ABOUT US    

Our mission

Hebei Jinsheng Zhongtai Industrial Co., Ltd. is located in Shijiazhuang, the pharmaceutical capital of China, covering an area of 65000 square meters with a total investment of 50 million US dollars. It has an annual production capacity of 60000 tons and is one of the important chemical pharmaceutical and pharmaceutical intermediate manufacturers in Asia. A first-class research and development team composed of internationally renowned chemists and senior domestic experts and professors. A management team led by an experienced CEO in the chemical industry and a team of employees who have undergone rigorous training and assessment. World leading research and development facilities, production equipment, and automated production control systems. Advanced testing instruments and professional quality control personnel ensure that the whole process quality control of products is achieved from raw material supply, production process, inspection and delivery.

At present, the company has 282 employees and has 9 commercial production workshops, including 3 GMP workshops and 1 CDMO workshop. The main products are meglumine, trimetazidine hydrochloride, intermediates of quetiapine fumarate, intermediates of paroxetine hydrochloride, and intermediates of nategline. So far, the company has 36 high-tech products, applied for 25 invention patents, and authorized 15 patents.

In order to accelerate the development of the enterprise, the three specialized workshops set up by the company in the chemical industry park have gradually been put into production. We will continue to be market-oriented, rely on scientific research and innovation, fully leverage our own advantages, and wholeheartedly provide more high-quality products and services to customers at home and abroad. We are willing to seek development and win-win cooperation with friends from all walks of life in society.

After years of development, our company has international customers all over the world. Including the United States, Russia, Canada, and multiple countries in Africa and Southeast Asia.